These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 25805937)

  • 1. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
    Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
    World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
    Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
    Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis.
    Bai H; Huangz X; Jing L; Zeng Q; Han L
    Hepatogastroenterology; 2015; 62(138):373-7. PubMed ID: 25916066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients.
    Postlewait LM; Squires MH; Kooby DA; Weber SM; Scoggins CR; Cardona K; Cho CS; Martin RCG; Winslow ER; Maithel SK
    HPB (Oxford); 2016 Feb; 18(2):192-199. PubMed ID: 26902139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Baba H; Adam R
    Br J Surg; 2017 Apr; 104(5):570-579. PubMed ID: 28112813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
    Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
    World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-controlled study comparing peri-operative and cancer-related outcomes after major hepatectomy and parenchymal sparing hepatectomy for metastatic colorectal cancer.
    Lordan JT; Roberts JK; Hodson J; Isaac J; Muiesan P; Mirza DF; Marudanayagam R; Sutcliffe RP
    HPB (Oxford); 2017 Aug; 19(8):688-694. PubMed ID: 28495437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases.
    Ko S; Jo H; Yun S; Park E; Kim S; Seo HI
    World J Gastroenterol; 2014 Jan; 20(2):525-31. PubMed ID: 24574721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between percutaneous radiofrequency ablation and surgical hepatectomy focusing on local disease control rate for colorectal liver metastases.
    Nishiwada S; Ko S; Mukogawa T; Ishikawa H; Matsusaka M; Nakatani T; Kikuchi E; Watanabe A
    Hepatogastroenterology; 2014; 61(130):436-41. PubMed ID: 24901157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis.
    van Amerongen MJ; Jenniskens SFM; van den Boezem PB; Fütterer JJ; de Wilt JHW
    HPB (Oxford); 2017 Sep; 19(9):749-756. PubMed ID: 28687147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.
    Koh PS; Chan AC; Cheung TT; Chok KS; Dai WC; Poon RT; Lo CM
    HPB (Oxford); 2016 Jan; 18(1):72-8. PubMed ID: 26776854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.
    Beamish P; Lemke M; Li J; Dixon E; Abraham MT; Hernandez-Alejandro R; Bennett S; Martel G; Karanicolas PJ;
    HPB (Oxford); 2017 Aug; 19(8):675-681. PubMed ID: 28495435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
    Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
    Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
    Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.